Diphenhydramine hydrochloride 0.001 % / naphazoline hydrochloride 0.05 % Ophthalmic Solution
RxNorm 1292022
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1292022 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: diphenhydramine hydrochloride 0.001 % / naphazoline hydrochloride 0.05 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Diphenhydramine hydrochloride 0.01 mg/ML / naphazoline hydrochloride 0.5 mg/ML Ophthalmic Solution
(Atom ID: 12345762)
SY
Synonym (SY):
Diphenhydramine hydrochloride 0.001 % / naphazoline hydrochloride 0.05 % Ophthalmic Solution
(Atom ID: 4608381)
TMSY
Tall Man Lettering Synonym (TMSY):
DiphenhydrAMINE hydrochloride 0.001 % / naphazoline hydrochloride 0.05 % Ophthalmic Solution
(Atom ID: 4610716)
TMSY